Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: Further evidence from a case- control study in Okinawa

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 5, 1998, Pages 413-417

  Sugimura, Haruhiko ^a   Wakai, Kenji ^b   Genka, Keiichiro ^c   Nagura, Kiyoko ^a   Igarashi, Hisaki ^a   Nagayama, Kazuhiro ^a   Ohkawa, Atsushi ^d   Baba, Satoshi ^a   Morris, Brian J ^e   Tsugane, Shoichiro ^f   Ohno, Yoshiyuki ^b   Gao, Changming ^g   Li, ZhongYou ^g   Takezaki, Toshiro ^h   Tajima, Kazuo ^h   Iwamasa, Teruo ⁱ  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c National Hospital Organization Okinawa National Hospital   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF SYDNEY   (Australia)

^f NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^g JIANGSU CANCER HOSPITAL   (China)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; ISOLEUCINE; VALINE;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ETHNIC GROUP; EXON; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP1A1; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; HUMANS; ISOLEUCINE; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VALINE;

EID: 7344261823     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kawajin, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. The CYPIAI gene and cancer susceptibility. Crit Rev. Oncol. Hematol , 14: 77-87, 1993.
2. Hamada, G. S., Sugimura, H , Suzuki, I , Nagura, K., Kiyokawa, E , Iwase, T , Tanaka, M , Takahashi, T., Watanabe, S., Kino, I., and Tsugane, S. The hemebinding region polymorphism of cytochrome P450IA1 (CypIAI). rather than the Rsal polymorphism of IIE1 (CypIIE), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol. Biomark. Prev , 4: 63-67, 1995.
3. Okada, T., Kawashima, K., Fukushi, S., Minakuchi, T., and Nishimura, S. Association between a cytochrome P450 CYPIAI genotype and incidence of lung cancer. Pharmacogenetics, 4: 333-340, 1994.
4. Kihara, M., Kihara, M , and Noda, K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYPIAI and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis (Lond.), 16. 2331-2336, 1995
5. Nakachi, K., Imai, K , Hayashi, S., and Kawajiri, K. Polymorphisms of the CYPIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993
6. Hirvonen, A , Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S., and Vainio, H. Point-mutational Mspl and Ile-Val polymorphisms closely linked in the CYPIAI gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomark Prev , 1: 485-489, 1992.
7. Ikawa, S., Uematsu, F , Watanabe, K., Kimpara, T , Osada, M., Hossain, A., Sagami. I., Kikuchi, H , and Watanabe, M Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism. Pharmacogenetics. 5 (Suppl ). S154-S160, 1995
8. London, S. J , Daly, A. K., Fairbrother, K. S., Holmes, C , Carpenter, C. L , Navidi, W. C., and Idle, J. R Lung cancer risk in African-Americans in relation to a race-specific CYPIAI polymorphism Cancer Res., 55: 6035-6037, 1995.
9. Oyama. T., Mitsudomi, T., Kawamoto, T., Ogami, A., Osaki, T., Kodama, Y., and Yasumoto, K. Detection of CYPIAI gene polymorphism using designed RFLP and distributions of CYPIAI genotypes in Japanese. Int Arch. Occup. Environ. Health. 67: 253-256, 1995.
10. Drakoulis, N , Cascorbi, I., Brockmoller, J., Gross, C R , and Roots, I. Polymorphisms m the human CYPIAI gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin Invest., 72. 240-248, 1994
11. Shields, P. G., Caporaso, N E , Falk, R. T., Sugimura, H . Trivers, G. E., Trump, B. F., Hoover, R. N., Weston, A., and Harris, C. C. Lung cancer, race, and a CYPIAI genetic polymorphism. Cancer Epidemiol. Biomark. Prev., 2: 481-485. 1993.
12. Sugimura, H., Hamada, G. S., Suzuki, I., Iwase, T , Kiyokawa, E., Kino, I , and Tsugane, S. CYP1AI and CYP2EI polymorphism and lung cancer, case-control study in Rio de Janeiro. Brazil Pharmacogenetics, 5: S145-S148, 1995
13. Xu, X., Kelsey, K. T., Wiencke, J. K.,. Wain, J. C., and Christiam, D. C. Cytochrome P450 CYPIAI Mspl polymorphism and lung cancer susceptibility Cancer Epidemiol. Biomark. Prev., 5: 687-692, 1996
14. Nakachi, K , Hayashi, S , Kawajiri, K , and Imai, K. Association of cigarette smoking and CYP1AI polymorphisms with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis (Lond), 16 2209-2213, 1995.
15. Lee, E J , Zhao, B , Moochhala, S M , and Ngoi, S. S. Frequency of mutant CYPIAI, NAT2 and GSTMI alleles in a normal Chinese population. Pharmacogenetics, 4: 355-358, 1994.
16. Zhao, B., Lee, E J , Wong, J. Y., Yeoh, P N., and Gong, N H. Frequency of mutant CYPIAI. NAT2 and GSTMi alleles in normal Indians and Malays Pharmacogenetics, 5: 275-280, 1995
17. Hanihara, K. The population history of the Japanese. Jpn. J Geriatr., 30. 923-931, 1993.
18. Hagihara, M., Shimura, T , Sato, K , Genga, K., Suzuki, M., and Tsuji, K HLA and tumor necrosis factor β gene polymorphisms in Okinawa lung cancer patients: comparative study with mainland Japan lung cancer patients. Hum Immunol., 43: 95-100, 1995.
19. Miller, J. M On Okinawa Maryland Med. J , 44: 927-928, 1995.
20. Tsugane, S. Ecological study on cancer mortality and lifestyle in Japan. Jpn. J. Cancer Clin., (Special Issue): 425-429, 1990.
21. Ohno, Y., Wakai, K., Genka, K., Ohmine, K , Kawamura, T., Tamakoslu, A., Aoki, R., Senda, M , Hayashi, Y., Nagao, K., Fukuma, S , and Aoki, K. Tea consumption and lung cancer risk a case-control study in Okinawa. Japan Jpn. J. Cancer Res., 86 1027-1034, 1995.
22. Wakai, K., Ohno, Y., Genka, K. Ohmine, K. Kawamura, T., Tamakoshi, A., Aoki, R., Kojima, M., Lin, Y. S , and Fukuma, S Smoking habits, local brand cigarettes and lung cancer risk in Okinawa Jpn. J. Epidemiol., 7: 99-105, 1997.
23. Mimura, G., Murakami, K , and Gushiken. M. Nutritional factors for longevity in Okinawa: present and future. Nutr. Health, 8: 159-163, 1992.
24. Tsugane, S., Gey, F., Ichinowatari, Y., Miyajima, Y , Yamaguchi, M , Kanta, K , Kabuto, M , Takashima, Y., Todoroki, H., Tsuda, M., Akabane, M., Furuicht, Y , Hamada, G., and Watanabe, S. Cross-sectional epidemiologic study for assessing cancer risks at the population level I. Study design and participant rate. J. Epidemiol., 2: 75-81, 1992.
25. Zee, R. Y L., Griffith, L R., and Morris, B. J. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives Biochem. Biophys. Res Commun , 189: 965-971, 1992.
26. Shanmugartnain, K., and Sobin, L , H. Histological typing of upper respiratory tract tumors In: International Histological Classification of Tumors Geneva: WHO, 1978
27. Sambrook, J., Fritsch, E F., and Maniatis, T Molecular Cloning A Laboratory Manual Cold Spring Harbor. NY: Cold Spring Harbor Laboratory, 1989.
28. Breslow, N E , and Day, N. E Unconditional logistic regression for large strata In Statistical Methods in Cancer Research Lyon, France: IARC, 1980.
29. Armitage, P., and Berry. G. Goodness of fit of frequency distributions. In: Statistical Methods in Medical Research Oxford: Blackwell Science Ltd., 1994
30. Hirayasu, T., Iwamasa, T , Kamada, Y , Koyanagi, Y., Usuda, H., and Genka, K. Human papillomavirus DNA in squamous cell carcinoma of the lung J Clin Pathol., 49: 810-817, 1996
31. Nebert, D W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247: 267-281, 1991.
32. London, S. J , Daly, A K , Cooper, J , Navidi, W C , Carpenter, C. L , and Idle, J. R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst. (Bethesda), 87. 1246-1253, 1995
33. Sugimura, H . Suzuki, I . Hamada, G. S , Iwase, T , vTakahashi, T., Nagura, K., Iwata, H , Watanabe, S., Kino, I . and Tsugane. S Cytochrome P-450 IAI genotype in lung cancer patients and controls in Rio de Janeiro, Brazil Cancer Epidemiol. Biomark Prev., 3 145-148, 1994
34. Zhang, Z-Y , Fasco, M. J., Huang, L., Guengerich, P , and Kaminsky, L. S Characatenzation of purified human recombinant cytochrome P450IAI-Ile462 and -Val462: assessment of a role for the rare allele in carcinoaenesis. Cancer Res., 56. 3926-3933, 1996.